Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily J Lelliott

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Immunology Research|December 11, 2020
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in MelanomaEmily J Lelliott, Stefano Mangiola, Kelly M Ramsbottom, et al.
Nature Communications|January 30, 2025
Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screeningWei Jin, Yexuan Deng, John E La Marca, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Cancer Discovery|May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell MemoryEmily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Cell Reports|December 20, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunityTirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2019
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanomaShatha AbuHammad, Carleen Cullinane, Claire Martin, et al.
Nature Communications|August 21, 2025
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphomaMargaret A Potts, Shinsuke Mizutani, Yexuan Deng, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Immunology Research|December 11, 2020
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in MelanomaEmily J Lelliott, Stefano Mangiola, Kelly M Ramsbottom, et al.
Nature Communications|January 30, 2025
Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screeningWei Jin, Yexuan Deng, John E La Marca, et al.
Nature Communications|March 2, 2022
Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF<sup>V600</sup> melanomaLorey K Smith, Tiffany Parmenter, Margarete Kleinschmidt, et al.
Cancer Discovery|May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell MemoryEmily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Cell Reports|December 20, 2025
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunityTirta M Djajawi, Anne Huber, Sarahi Mendoza Rivera, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2019
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanomaShatha AbuHammad, Carleen Cullinane, Claire Martin, et al.
Nature Communications|August 21, 2025
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphomaMargaret A Potts, Shinsuke Mizutani, Yexuan Deng, et al.
Pageof 2